Supervisor Database Search
Guidance for ICAT Supervisors
The ICAT Supervisor list is reviewed annually by the partner universities and updated online in March/April each year.
You can read about the ICAT supervisor selection process and eligibility criteria below:
Terms of reference/guide to supervising ICAT Fellows.
You can read the terms of reference for supervisors actively supervising ICAT Fellows below:
Supervisor Database
Search for supervisors below. You can filter your search using the options and select multiple fields by holding CTRL (Cmd on Mac) + clicking multiple options in a list.
Full NameProfessor David Henshall
FutureNeuro
Royal College of Surgeons in Ireland
Webpage:futureneurocentre.ie
Email hidden; Javascript is required.
- neuroscience and mental health
- clinical trials
- Medicine
- Public Health
- Health Informatics
- Neurology
- Neurophysiology
The FutureNeuro Research Centre was established in 2017 and based in the Royal College of Surgeons in Ireland (RCSI), FutureNeuro is a world leading Science Foundation Ireland (SFI) Research Centre.
We are a collaboration between academic partners (RCSI, Trinity College Dublin, Dublin City University, NUI Galway and University College Dublin.), Clinicians and Industry.
Neurological diseases pose enormous scientific and clinical challenges. For many brain diseases we either have therapy with limited efficacy or we simply have no effective treatment. There are complex factors underlying this – and progress has been made - but a starting point is our still incomplete understanding of the mechanistic basis of many brain diseases. Diagnosis is the cornerstone of clinical care as it is the primary tool for decisions on treatment, prognosis and patient management - but for many neurological diseases this remains largely reliant on clinical examination and history. The ability to rapidly and sensitively detect biomarkers of disease and disease-risk, ideally in a point-of-care setting, would transform clinical practice. At FutureNeuro, we aim to deliver these advances in understanding disease initiation and progress. With this understanding, we will develop new technologies and solutions for the treatments, diagnosis and monitoring of chronic and rare neurological diseases.